Us Bancorp \De\ Cybin Inc. Transaction History

Us Bancorp \De\

$71.8 Billion
Q1 2024

A detailed history of Us Bancorp \De\ transactions in Cybin Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 750 shares of CYBN stock, worth $195. This represents 0.0% of its overall portfolio holdings.

Number of Shares

750

Holding current value

$195

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 07, 2024	BUY	$0.3 - $0.46 $225 - $345	750 New	750 $0
Q1 2022 May 11, 2022	BUY	$0.74 - $1.22 $7,400 - $12,200	10,000 New	10,000 $8,000

Others Institutions Holding CYBN

# of Institutions

109

Shares Held

243M

Call Options Held

Put Options Held

Deep Track Capital, LP Greenwich, CT

58.1M
Shares

$15.1 Million
0.79% of portfolio
Logos Global Management LP San Francisco, CA

40M
Shares

$10.4 Million
1.53% of portfolio
Avidity Partners Management LP Dallas, TX

34.9M
Shares

$9.07 Million
0.55% of portfolio
Sphera Funds Management Ltd. Tel Aviv, L3

25.6M
Shares

$6.65 Million
1.64% of portfolio
Octagon Capital Advisors LP New York, NY

18.6M
Shares

$4.84 Million
1.19% of portfolio

View Full List

About CYBIN INC.

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $43.2M
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

More about CYBN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account